Trial intelligence / Profile preview

DA-9601 (Stillen) in Acute and Chronic Gastritis

NCT07139886Phase 2Completed

Sponsor
Dong-A ST
Start
Mar 1997
Primary completion
Jul 1999
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of Stillen in acute gastritis and chronic gastritis (3 arms), sponsored by Dong-A ST. Primary endpoints: Change in Subjective and Objective Symptoms at 2 weeks, Gastroscopy Findings at 2 weeks and 2 more. Started Mar 1997; status: completed.

02

Drugs

Stillen
03

Conditions

acute gastritischronic gastritis

Beyond the preview

Go deeper on NCT07139886.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07139886.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call